248 related articles for article (PubMed ID: 30914434)
1. Interactions of
Lin HY; Callan CY; Fang Z; Tung HY; Park JY
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk associated loci in African Americans.
Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.
Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA
Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899
[TBL] [Abstract][Full Text] [Related]
4. Contribution of lncRNA CASC8, CASC11, and PVT1 Genetic Variants to the Susceptibility of Coronary Heart Disease.
Lu Y; Yuan W; Wang L; Ning M; Han Y; Gu W; Zhao T; Shang F; Guo X
J Cardiovasc Pharmacol; 2021 Jun; 77(6):756-766. PubMed ID: 34001726
[TBL] [Abstract][Full Text] [Related]
5. GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP).
Xu Z; Bensen JT; Smith GJ; Mohler JL; Taylor JA
Prostate; 2011 Jun; 71(8):881-91. PubMed ID: 21456070
[TBL] [Abstract][Full Text] [Related]
6. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
7. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL
Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
[TBL] [Abstract][Full Text] [Related]
9. The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer.
Umemori M; Kurata M; Yamamoto A; Yamamoto K; Ishibashi S; Ikeda M; Tashiro K; Kimura T; Sato S; Takahashi H; Kitagawa M
Med Mol Morphol; 2020 Sep; 53(3):156-167. PubMed ID: 31932969
[TBL] [Abstract][Full Text] [Related]
10. CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis.
Capik O; Sanli F; Kurt A; Ceylan O; Suer I; Kaya M; Ittmann M; Karatas OF
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):891-902. PubMed ID: 33753875
[TBL] [Abstract][Full Text] [Related]
11. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
[TBL] [Abstract][Full Text] [Related]
12. Fine-mapping of IL16 gene and prostate cancer risk in African Americans.
Batai K; Shah E; Murphy AB; Newsome J; Ruden M; Ahaghotu C; Kittles RA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2059-68. PubMed ID: 22923025
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide two-locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross-population study.
Shen J; Li Z; Song Z; Chen J; Shi Y
Int J Cancer; 2017 May; 140(9):2075-2084. PubMed ID: 28124475
[TBL] [Abstract][Full Text] [Related]
14. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
[TBL] [Abstract][Full Text] [Related]
15. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
[TBL] [Abstract][Full Text] [Related]
16. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.
Salinas CA; Kwon E; Carlson CS; Koopmeiners JS; Feng Z; Karyadi DM; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1203-13. PubMed ID: 18483343
[TBL] [Abstract][Full Text] [Related]
17. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
18. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
[TBL] [Abstract][Full Text] [Related]
19. EphB2 SNPs and sporadic prostate cancer risk in African American men.
Robbins CM; Hooker S; Kittles RA; Carpten JD
PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
[TBL] [Abstract][Full Text] [Related]
20. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
